Want to see IN:NIVABUPA full AI Analyst Report?
Top Page
Niva Bupa Health Insurance Company Limited
(NIVABUPA)
Select Model
Select Model
Rating:55Neutral
Price Target:
₹75.00
▼(-9.00% Downside)
Action:Reiterated
Date:08/21/26
The score is held up by stable financial footing (low leverage) and continued positive cash generation, but is reduced by sharp profitability compression and weaker year-over-year cash flow. Technical indicators are bearish and valuation is rich (high P/E with no dividend yield provided), which further weigh on the overall rating.
Positive Factors
Strong Revenue Growth
FY2026 revenue expanded sharply and gross margin improved, demonstrating strong reported business growth and better gross economics. If sustained, this scale can broaden premium volume and support operating leverage, although profitability conversion remains important.
Negative Factors
Margin Compression
Profitability weakened materially despite the sharp revenue increase, showing that growth has not yet translated into stronger operating or net earnings. Persistent margin pressure could limit reinvestment capacity and make future results more sensitive to costs, pricing, or claims experience.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
FY2026 revenue expanded sharply and gross margin improved, demonstrating strong reported business growth and better gross economics. If sustained, this scale can broaden premium volume and support operating leverage, although profitability conversion remains important.
Read all positive factors
Niva Bupa Health Insurance Company Limited (NIVABUPA) vs. iShares MSCI India ETF (INDA)
Market Cap
₹135.12B
Dividend YieldN/A
Average Volume (3M)85.58K
Price to Earnings (P/E)38.7
Beta (1Y)0.89
Revenue Growth38.81%
EPS Growth151.01%
CountryIN
Employees9,834
SectorGeneral
Sector StrengthN/A
IndustryInsurance - Life
Share Statistics
EPS (TTM)1.96
Shares Outstanding1,849,644,700
10 Day Avg. Volume63,009
30 Day Avg. Volume85,575
Financial Highlights & Ratios
PEG Ratio-2.62
Price to Book (P/B)4.17
Price to Sales (P/S)1.99
P/FCF Ratio15.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹102.50Price Target Upside24.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)2.63
Revenue Forecast (FY)₹96.50B
Niva Bupa Health Insurance Company Limited Business Overview & Revenue Model
Company Description
Niva Bupa Health Insurance Company Limited provides health insurance products in India. It offers health insurance plans, such as individual, family, NRIs, senior citizens, personal accident, critical illness; travel insurance, including internati...
How the Company Makes Money
Niva Bupa primarily makes money by underwriting health insurance policies and earning income from premiums. Customers (individuals/families) and corporate/group clients pay periodic premiums in exchange for coverage of eligible medical expenses, a...
Niva Bupa Health Insurance Company Limited Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
72
Positive
Cash Flow
63
Positive
| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 77.95B | 66.95B | 63.30B | 44.27B | 27.99B | 18.41B |
| Gross Profit | 47.01B | 54.68B | 8.13B | 32.33B | 26.08B | 17.20B |
| EBITDA | 4.11B | 1.27B | 3.02B | 1.64B | 896.65M | -1.54B |
| Net Income | 3.60B | 1.31B | 2.14B | 818.50M | 125.40M | -1.97B |
Balance Sheet | ||||||
| Total Assets | 118.82B | 112.76B | 94.51B | 61.92B | 38.77B | 27.19B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.59B | 13.08B | 5.95B | 4.59B | 4.00B |
| Total Debt | 2.61B | 2.50B | 2.50B | 2.50B | 2.50B | 2.50B |
| Total Liabilities | 80.46B | 80.77B | 61.59B | 22.77B | 10.21B | 1.60B |
| Stockholders Equity | 38.36B | 31.99B | 44.94B | 39.15B | 28.55B | 25.58B |
Cash Flow | ||||||
| Free Cash Flow | 7.66B | 8.56B | 15.86B | 8.24B | 5.55B | 3.09B |
| Operating Cash Flow | 7.61B | 9.05B | 16.27B | 8.30B | 5.93B | 3.38B |
| Investing Cash Flow | -7.50B | -9.61B | -23.48B | -18.82B | -8.29B | -7.23B |
| Financing Cash Flow | -124.20M | -52.10M | 7.98B | 10.93B | 2.80B | 3.74B |
Niva Bupa Health Insurance Company Limited Technical Analysis
Negative
82.42
Price Trends
81.95
Negative
83.26
Negative
79.54
Negative
Market Momentum
-2.07
Positive
41.14
Neutral
26.51
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:NIVABUPA, the sentiment is Negative. The current price of 82.42 is above the 20-day moving average (MA) of 78.41, above the 50-day MA of 81.95, and above the 200-day MA of 79.54, indicating a bearish trend. The MACD of -2.07 indicates Positive momentum. The RSI at 41.14 is Neutral, neither overbought nor oversold. The STOCH value of 26.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:NIVABUPA.
Niva Bupa Health Insurance Company Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹1.73T | 65.93 | ― | 0.16% | -0.43% | 4.44% | |
69 Neutral | ₹316.36B | 37.33 | ― | ― | 20.55% | 42.94% | |
58 Neutral | ₹1.16T | 57.97 | ― | 0.75% | 5.03% | 4.87% | |
57 Neutral | ₹651.97B | 38.85 | ― | 0.36% | -8.37% | 35.27% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | ₹135.12B | 38.70 | ― | ― | 38.81% | 151.01% | |
52 Neutral | ₹478.47B | 421.25 | ― | 0.63% | 4.89% | -59.23% |
* General Sector Average
IN:NIVABUPA
Niva Bupa Health Insurance Company Limited
75.77
-4.44
-5.54%
IN:HDFCLIFE
HDFC Life Insurance Co. Ltd.
530.95
-229.39
-30.17%
IN:ICICIPRULI
ICICI Prudential Life Insurance Co. Ltd.
452.80
-145.77
-24.35%
IN:MFSL
Max Financial Services Limited
1,347.00
-257.00
-16.02%
IN:SBILIFE
SBI Life Insurance Co. Ltd.
1,730.00
-38.94
-2.20%
IN:STARHEALTH
Star Health & Allied Insurance Co. Ltd.
534.70
77.50
16.95%
Niva Bupa Health Insurance Company Limited Corporate Events
AM Best Assigns Strong Credit Ratings to Niva Bupa Health Insurance
Sep 17, 2026
AM Best has assigned Niva Bupa Health Insurance Company Limited a Financial Strength Rating of A- (Excellent), a Long-Term Issuer Credit Rating of “a-” (Excellent), and an India National Scale Rating of aaa.IN (Exceptional), all with a...
Niva Bupa boosts capital with new ESOP share allotment
Aug 26, 2026
Niva Bupa Health Insurance Company Limited has allotted 411,000 new equity shares with a face value of ₹10 each under its Employee Stock Option Plan 2020 and Employee Stock Option Plan 2024. The shares, split between the two schemes, were is...
ICRA Reaffirms Niva Bupa’s AAA Rating and Backs ₹500 Crore Sub‑Debt Plan
Aug 20, 2026
Niva Bupa Health Insurance Company Limited has disclosed that ICRA Limited has reaffirmed its issuer rating at [ICRA]AAA with a stable outlook, underscoring the insurer’s strong credit profile and robust debt‑servicing capability. ICRA...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.